Bezlotoxumab as Secondary Prophylaxis for C. Difficile in High-risk Hospitalized Patients Exposed to Antibiotics.

Stopped Slow enrollment due to COVID19 , change in practice with standardized use of oral vancomycin prophylaxis

Conditions

• Clostridium Difficile

Interventions

• DRUG: Bezlotoxumab

Sponsor

Montefiore Medical Center

Collaborators

• [object Object]